PMID: 6444393Jan 1, 1980Paper

Further evidence that serotonin may be a physiological melanocyte-stimulating hormone-releasing factor in the lizard Anolis carolinensis

General and Comparative Endocrinology
H P Levitin

Abstract

No abstract listed.

References

Serotonin and MSH secretion: effect of parachlorophenylalanine on the pituitary cytology of the eel

Jul 13, 1978·Cell and Tissue Research·M Olivereau

Light and electron microscopic study of the pars intermedia of the lizard, Klauberina riversiana

Jan 1, 1970·Zeitschrift für Zellforschung und mikroskopische Anatomie·E M Rodríguez, J La Pointe

Physiological color changes in reptiles

May 1, 1969·American Zoologist·M E Hadley, J M Goldman

Observations on the fine structure of the pars intermedia in the lizard Anolis carolinensis

Feb 1, 1972·General and Comparative Endocrinology·M S Forbes

❮ Previous
Next ❯

Citations

Serotonin binding sites. I. Structures of sites on myelin basic protein, LHRH, MSH, ACTH, interferon, serum albumin, ovalbumin and red pigment concentrating hormone

Apr 1, 1984·Brain Research Bulletin·R S Root-Bernstein, F C Westall

Effects of the serotonin-uptake inhibitor, fluoxetine, on immunoreactive serotonin innervation in the rat pituitary gland

Aug 1, 1987·Brain Research Bulletin·L C SalandF Comunas

5-HT1A/1B receptors as targets for optimizing pigmentary responses in C57BL/6 mouse skin to stress

Mar 4, 2014·PloS One·Hua-Li WuJing Shang

Potassium-induced secretion of melanocyte-stimulating hormone from the melanotrophs of the neurointermediate lobe of the lizard Anolis carolinensis

Dec 22, 1999·General and Comparative Endocrinology·H J LyonsP S Taraskevich

Serotonin induces melanogenesis via serotonin receptor 2A

Jun 30, 2011·The British Journal of Dermatology·H J LeeC H Lee

NK1R/5-HT1AR interaction is related to the regulation of melanogenesis

Feb 13, 2018·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Huali WuJing Shang

Immunoglobulin (Gm) markers and alpha 1-antitrypsin (PI) types in rheumatoid arthritis and early onset chronic active hepatitis

Apr 1, 1984·Journal of Immunogenetics·L J Walsh, D W Cox

Immunoglobulin allotypes in patients in end-stage renal failure

Aug 1, 1985·Journal of Immunogenetics·G J Laundy, B A Bradley

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

ContactHelpTerms Privacy Cookies
© 2022 Meta ULC. All rights reserved